HEALTH OF WOMAN.2016.7(113):121–124; doi 10.15574/HW.2016.113.121 
 

Diagnostic treatment approach for cervical intraepithelial neoplasia in women of reproductive age with benign uterine hyperplasia

Kondratyuk V. K., Zadorozhnaya T. D., Narolskaya A. I,, Gorban N. Ye., Botsyun P. N., Pustovalova O. I.

SI «Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine», Kiev

CSD «CSD Health care», Kyiv

The article presents an analysis of the complex treatment results of reproductive age patients with uterine leiomyoma and dysplastic lesions of the squamous epithelium of the cervix which included anti-inflammatory therapy and radiowave surgery. The use of complex therapeutic measures in patients with uterine leiomyoma and dysplastic lesions of the squamous epithelium of the cervix allowed to reduce the epithelialization period of postoperative wound surface and to decrease the incidence of complications and recurrences.

Key words: uterine leiomyoma, dysplastic lesions of squamous epithelium, conservative treatment, radiowave surgery, complications, recurrences.

REFERENCES

1. Jemal A, Bray F, Melissa M, Ferlay J et al. 2011. Global cancer statistics. Cancer J. for Clinicians 61(2):69–90. http://dx.doi.org/10.3322/caac.20107; PMid:21296855

2. Potapov VO, Shponka OV, Havrysh LP, Bilodid OO. 2013. Epidemiolohiia ta chynnyky ryzyku dysplazii i raku shyiky matky. Med.-sots. probl. sim’i 18;3:55–62.

3. Payson M, Leppert P, Segars J. 2006. Epidemiology of myomas. Obstet. Gynecol. Clin. North. Am. 33;1:1–11. http://dx.doi.org/10.1016/j.ogc.2005.12.004; PMid:16504803 PMCid:PMC4152898

4. Fernandez H. 2011. Update of myoma management – introduction. J. Gynecol. Obstet. Biol. Reprod. 40;8:856–860. Paris. http://dx.doi.org/10.1016/j.jgyn.2011.09.017; PMid:22056187

5. Buyanova SN, Mgeliashvili MV, Petrakova SA. 2008. Sovremennyie predstavleniya ob etiologii, patogeneze i morfogeneze miomyi matki. Rossiyskiy vestnik akushera-ginekologa 8;6:45–51.

6. Donskaya YuV, Potapov VA, Medvedev MV. 2014. Novyie podhodyi k organosohranyayuschemu lecheniyu giperplasticheskih protsessov endometriya u bolnyih s leyomiomoy matki. UnIversum: Meditsina i farmakologiya: elektron. nauchn. zhurn 8(9). URL: http://7universum.com/ru/med.

7. Kiselev VI, Lyashenko AA. 2005. Molekulyarnyie mehanizmyi regulyatsii giperplasticheskih protsessov. M, Izdatelstvo Dimitreyd grafik grupp:348.

8. Tatarchuk TF, Kalugina LV. 2013. K voprosu o profilaktike i terapii gormonozavisimyih giperproliferativnyih zabolevaniy u zhenschin. Zdorove zhenschiny 7:51–57.

9. Kondratiuk VK, Narolska AI, Horban NIe, Ovchar IV. 2016. Sposib profilaktyky uskladnen khirurhichnoho likuvannia dysplazii shyiky matky. Informatsiinyi lyst pro novovvedennia v sferi okhorony zdorov’ia 1:4.

10. Ievleva NF, Chizhova GV, Permina NE. 2013. Cravnitelnaya effektivnost razlichnyih metodov lecheniya zabolevaniy sheyki matki. Dalnevostochnyiy meditsinskiy zhurnal 3:32–34.

11. Leminen H, Hurskainen R. 2012. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int. J. Womens Health 4:413–421. PMid:22956886 PMCid:PMC3430088

12. Lukes AS, Moore KA, Muse KN, Gersten JK. 2010. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet. Gynecol. 116(4):865–875. http://dx.doi.org/10.1097/aog.0b013e3181f20177